List view / Grid view
8 February 2016 | By SMi Group
SMi will open its doors to host RNA Therapeutics 2016 in just 1 week on 15th and 16th February in Central London...
8 February 2016 | By Victoria White
Biogen’s new membership follows the launch of the new CTTV Target Validation Platform, which helps researchers identify therapeutic targets for new medicines...
8 February 2016 | By Victoria White
Peptidyl arginine deiminase 4 (PAD4) is a protein that plays a role in the development of inflammatory diseases like arthritis...
8 February 2016 | By Victoria White
NIH says one of the highest priorities is to establish conclusively what role, if any, Zika virus has played in the marked increase in suspected microcephaly cases...
5 February 2016 | By Victoria White
New research suggests that drugs to prevent, rather than encourage, cell death might be effective at fighting cancer - contrary to how many of the current chemotherapy drugs work...
5 February 2016 | By Victoria White
Quantum Genomics has established a US Clinical Advisory Board of renowned cardiologists and cardiovascular researchers...
4 February 2016 | By Victoria White
Compounds that produce elevated levels of TTP in humans may offer an effective treatment for inflammatory diseases, such as rheumatoid arthritis and multiple sclerosis...
4 February 2016 | By Victoria White
Researchers have discovered that a pro-inflammatory signalling protein, called IL-33, shows increased expression in AMD...
4 February 2016 | By Victoria White
Researchers showed that virus-like particles carrying LXY-30 could home in on breast cancer cells both in a laboratory dish and in a mouse model...
4 February 2016 | By Victoria White
The new site will be located at in the Wielkopolska Centre of Advanced Technologies, Poznan, and commence research activities in the summer of 2016...
3 February 2016 | By Victoria White
XMT-1522 is an investigational, Fleximer-based ADC therapy that targets HER2-expressing tumours, including breast, gastric and non-small cell lung cancers...
3 February 2016 | By Victoria White
A new ‘roadmap’ document published today outlines how The London Cancer Hub will become a world-leading life-science campus...
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
3 February 2016 | By Victoria White
The enhanced agreement will accelerate Adaptimmune’s lead clinical cancer programme, an affinity enhanced T-cell immunotherapy targeting NY-ESO-1...
3 February 2016 | By Victoria White
This award will give Dr Echalier access to the drug discovery capabilities of Domainex in support of her research...
